Current position

Renaissance Technologies LLC’s Gilead Sciences Inc (GILD) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Renaissance Technologies LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2013Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares16.96MHighest verified quarter-end share count
Quarters reported50Verified quarters with shares above zero
What happened?

Renaissance Technologies LLC first reported Gilead Sciences Inc in Q3 2013. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. Renaissance Technologies LLC currently reports 2.22M shares. The latest verified filing showed: Bought 3.0% more.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Bought 3.0% more+64.85K shares · 2.22M shares reported after the change
Filing context

Quarter-end price $126.34 · Estimated holding basis $70.30

Q1 2026
Sold 22.8% of the position−636.20K shares · 2.15M shares remained
Filing context

Quarter-end price $139.37 · Estimated holding basis $68.61

Q4 2025
Sold 49.0% of the position−2.67M shares · 2.79M shares remained
Filing context

Quarter-end price $122.74 · Estimated holding basis $68.61

Q3 2025
Sold 3.6% of the position−203.65K shares · 5.46M shares remained
Filing context

Quarter-end price $111.00 · Estimated holding basis $68.61

Q2 2025
Bought 3.9% more+215.25K shares · 5.67M shares reported after the change
Filing context

Quarter-end price $110.87 · Estimated holding basis $68.61

Q1 2025
Bought 2.3% more+121.40K shares · 5.45M shares reported after the change
Filing context

Quarter-end price $112.05 · Estimated holding basis $66.94

Portfolio importance

How important is Gilead Sciences Inc in Renaissance Technologies LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.4%Q2 2026
Current rank#35of 3140 reported positions
Peak portfolio weight1.2%Q1 2023
Best historical rank#2Q3 2017
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$152.672026-09-22

Market context only; not an investor transaction price.

Latest filing quarter-end price$126.34Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$70.30Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-13
Open SEC filing ↗

Coverage is bounded to the institution’s top reported positions and material events rather than every security in each Form 13F. The filing reflects reportable U.S.-listed holdings, not Renaissance’s secret models, complete trading book, exact trade dates or execution prices.